BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36238732)

  • 1. Association between Texture Analysis Parameters and Molecular Biologic KRAS Mutation in Non-Mucinous Rectal Cancer.
    Jo SJ; Kim SH; Park SJ; Lee Y; Son JH
    Taehan Yongsang Uihakhoe Chi; 2021 Mar; 82(2):406-416. PubMed ID: 36238732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing MRI features of rectal cancers with different KRAS status.
    Xu Y; Xu Q; Ma Y; Duan J; Zhang H; Liu T; Li L; Sun H; Shi K; Xie S; Wang W
    BMC Cancer; 2019 Nov; 19(1):1111. PubMed ID: 31727020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer?
    Xu Y; Xu Q; Sun H; Liu T; Shi K; Wang W
    Eur Radiol; 2018 Jul; 28(7):3059-3065. PubMed ID: 29450716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer.
    Oh JE; Kim MJ; Lee J; Hur BY; Kim B; Kim DY; Baek JY; Chang HJ; Park SC; Oh JH; Cho SA; Sohn DK
    Cancer Res Treat; 2020 Jan; 52(1):51-59. PubMed ID: 31096736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between oncogenic RAS mutation and radiologic-pathologic findings in patients with primary rectal cancer.
    Jo SJ; Kim SH
    Quant Imaging Med Surg; 2019 Feb; 9(2):238-246. PubMed ID: 30976548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT Texture Analysis: A Potential Biomarker for Evaluating KRAS Mutational Status in Colorectal Cancer.
    Cao J; Wang GR; Wang ZW; Jin ZY
    Chin Med Sci J; 2020 Dec; 35(4):306-314. PubMed ID: 33413746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer.
    Cui Y; Liu H; Ren J; Du X; Xin L; Li D; Yang X; Wang D
    Eur Radiol; 2020 Apr; 30(4):1948-1958. PubMed ID: 31942672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer.
    Liu H; Yin H; Li J; Dong X; Zheng H; Zhang T; Yin Q; Zhang Z; Lu M; Zhang H; Wang D
    J Magn Reson Imaging; 2022 Dec; 56(6):1659-1668. PubMed ID: 35587946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative Evaluation of the Value of Quantitative Parameters of Dual-energy CT and MRI for KRAS Mutation in Rectal Cancer].
    Lin XQ; Han T; Jing MY; Deng LN; Zhang B; Zhou JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):606-613. PubMed ID: 36065693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of texture analysis on T2-weighted MR for differentiating tumor deposits from mesorectal nodes in rectal cancer patients, in a retrospective cohort.
    Atre ID; Eurboonyanun K; Noda Y; Parakh A; O'Shea A; Lahoud RM; Sell NM; Kunitake H; Harisinghani MG
    Abdom Radiol (NY); 2021 Feb; 46(2):459-468. PubMed ID: 32700214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
    Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
    Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
    Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
    Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps.
    Yin JD; Song LR; Lu HC; Zheng X
    World J Gastroenterol; 2020 May; 26(17):2082-2096. PubMed ID: 32536776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion kurtosis imaging-derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings.
    Cui Y; Cui X; Yang X; Zhuo Z; Du X; Xin L; Yang Z; Cheng X
    J Magn Reson Imaging; 2019 Sep; 50(3):930-939. PubMed ID: 30637861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of KRAS Mutation Status Prediction Model for Colorectal Cancer Based on Medical Imaging.
    Ren Z; Che J; Wu XW; Xia J
    Comput Math Methods Med; 2021; 2021():3953442. PubMed ID: 34976107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Aker M; Ganeshan B; Afaq A; Wan S; Groves AM; Arulampalam T
    Dis Colon Rectum; 2019 Feb; 62(2):163-170. PubMed ID: 30451764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study.
    Gültekin MA; Türk HM; Beşiroğlu M; Toprak H; Yurtsever I; Yilmaz TF; Sharifov R; Uysal Ö
    Eur J Radiol; 2020 Apr; 125():108895. PubMed ID: 32109834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative T2 Mapping to Discriminate Mucinous from Nonmucinous Adenocarcinoma in Rectal Cancer: Comparison with Diffusion-weighted Imaging.
    Zhang J; Ge Y; Zhang H; Wang Z; Dou W; Hu S
    Magn Reson Med Sci; 2022 Oct; 21(4):593-598. PubMed ID: 34421090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture analysis on bi-parametric MRI for evaluation of aggressiveness in patients with prostate cancer.
    Baek TW; Kim SH; Park SJ; Park EJ
    Abdom Radiol (NY); 2020 Dec; 45(12):4214-4222. PubMed ID: 32740864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.